Webinar
EGFR-TKI in NSCLC – How do we manage them in India?
Date:
Sat 31 Aug, 2019 2:00–3:00pm
Duration:
1 hour
The session will cover:
- Lung cancer burden in India and the world
- How common is EGFR mutation in India
- Tests for EGFR mutations
- First line treatment option
- Re-biopsy
- Reason for resistance
- Second line treatment option
- Third line treatment option
- The difference that we have made in the outcome
About the presenter:
Dr. Kumar Prabhash, Professor of Medical Oncology at Tata Memorial Hospital, Mumbai
- His career has taken him through 25 years of study, research, teaching and administration in this field in various capacities
- He has promulgated various initiatives and patient programs
- He is the recipient of Madam Curie fellowship as well as the IAEA Fellowship
- He has been a recipient of the MOSCON award
- He has been an invited speaker at ASCO
